Neoadjuvant Chemohormonal Therapy Aids Locally Advanced Prostate Cancer
Significant benefits in terms of three-year biochemical progression-free survival seen for NCHT versus neoadjuvant hormonal therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.